Storage and handling
Other information phenylketonurics: contains phenylalanine 0.28 mg per tablet store at room temperature in a dry place
Other information phenylketonurics: contains phenylalanine 0.28 mg per tablet store at room temperature in a dry place
DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Drug Facts
Active ingredient (in each chewable tablet)
Meclizine HCl, USP 25 mg
Purpose
Antiemetic
Uses
prevents and treats nausea, vomiting or dizziness due to motion sickness
Warnings
Do not use in children under 12 years of age unless directed by a doctor.
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
If pregnant or breast-feeding, ask a health professional before use
Keep out of reach of children.
In case of overdose, get medical help or contact the poison control center immediately.
Directions
Other information
Inactive ingredients Aspartame, croscarmellose sodium, dextrose, FD&C red #40 lake, magnesium stearate, maltodextrin, microcrystalline cellulose, natural and artificial flavors, silicon dioxide, sodium sulfate, sugar, tricalcium phosphate.
Questions? If you have any questions or comments or to report an adverse event, please contact (800) 795-9775.
Distributed by: Plus Pharma, Commack, NY 11725
*Plus Pharma is not affiliated with the owner of the registered trademark Bonine®.
NDC: 71335-0143-1: 30 Tablets in a BOTTLE
NDC: 71335-0143-2: 20 Tablets in a BOTTLE
NDC: 71335-0143-3: 25 Tablets in a BOTTLE
NDC: 71335-0143-4: 40 Tablets in a BOTTLE
NDC: 71335-0143-5: 60 Tablets in a BOTTLE
NDC: 71335-0143-6: 90 Tablets in a BOTTLE
NDC: 71335-0143-7: 8 Tablets in a BOTTLE
NDC: 71335-0143-8: 14 Tablets in a BOTTLE
NDC: 71335-0143-9: 10 Tablets in a BOTTLE
NDC: 71335-0143-0: 120 Tablets in a BOTTLE
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-0143-0 | Meclizine HCl 25 mg | 120 in 1 BOTTLE | TABLET, CHEWABLE | 120 | 7 | |
| 71335-0143-1 | Meclizine HCl 25 mg | 30 in 1 BOTTLE | TABLET, CHEWABLE | 30 | 7 | |
| 71335-0143-2 | Meclizine HCl 25 mg | 20 in 1 BOTTLE | TABLET, CHEWABLE | 20 | 7 | |
| 71335-0143-3 | Meclizine HCl 25 mg | 25 in 1 BOTTLE | TABLET, CHEWABLE | 25 | 7 | |
| 71335-0143-4 | Meclizine HCl 25 mg | 40 in 1 BOTTLE | TABLET, CHEWABLE | 40 | 7 | |
| 71335-0143-5 | Meclizine HCl 25 mg | 60 in 1 BOTTLE | TABLET, CHEWABLE | 60 | 7 | |
| 71335-0143-6 | Meclizine HCl 25 mg | 90 in 1 BOTTLE | TABLET, CHEWABLE | 90 | 7 | |
| 71335-0143-7 | Meclizine HCl 25 mg | 8 in 1 BOTTLE | TABLET, CHEWABLE | 8 | 7 | |
| 71335-0143-8 | Meclizine HCl 25 mg | 14 in 1 BOTTLE | TABLET, CHEWABLE | 14 | 7 | |
| 71335-0143-9 | Meclizine HCl 25 mg | 10 in 1 BOTTLE | TABLET, CHEWABLE | 10 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-0143 | MECLIZINE HCL 25 MG (MECLIZINE HYDROCHLORIDE) TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 7 | Legacy NDC, 10 package rows | 20220304_a0d519ec-8a3d-4486-8364-e8ed40bef5cb.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-0143-0 | EA - Each | 71335-0143 | fedf6fec-f861-4122-ac10-2396796a6fc7 | 1 | 2024-04-05 |
| 71335-0143-1 | EA - Each | 71335-0143 | 3619d9a6-18d2-4de3-8d25-150570472789 | 1 | 2022-11-07 |
| 71335-0143-2 | EA - Each | 71335-0143 | 6a957adb-0e5d-4642-993f-3d7cc352a7ee | 1 | 2022-11-07 |
| 71335-0143-3 | EA - Each | 71335-0143 | b3323381-4953-4af1-9c7b-6f1a2b0e2d30 | 1 | 2022-11-07 |
| 71335-0143-4 | EA - Each | 71335-0143 | 6d3c6555-a6fa-4b12-b7a6-c3689382ddfc | 1 | 2022-11-07 |
| 71335-0143-6 | EA - Each | 71335-0143 | dfed786b-587e-43c4-a413-50aa250bbcec | 1 | 2022-11-07 |
| 71335-0143-7 | EA - Each | 71335-0143 | 573b57e2-d747-4912-ac17-c2fda1ddc4ed | 1 | 2022-11-07 |
| 71335-0143-8 | EA - Each | 71335-0143 | 3274ca5b-d7bb-4276-a151-bdd5cda0c500 | 1 | 2022-11-07 |
| 51645-994-01 | EA - Each | 51645-994 | 094ec1d6-7d2f-47b2-bfba-42e4d43dd5be | 1 | 2016-03-04 |
| 51645-994-10 | EA - Each | 51645-994 | 1e7b29ee-6984-4e20-aacf-83d5b646caee | 1 | 2016-03-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71335-0143 | 71335-0143-1, 71335-0143-2, 71335-0143-3, 71335-0143-4, 71335-0143-5, 71335-0143-6, 71335-0143-7, 71335-0143-8, 71335-0143-9, 71335-0143-0 |
| 51645-994 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| SUCROSE | C151H8M554 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DEXTROSE, UNSPECIFIED FORM | IY9XDZ35W2 | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SODIUM SULFATE | 0YPR65R21J | IACT |
| TRICALCIUM PHOSPHATE | K4C08XP666 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1918e9e2-8022-49ec-81fd-a9eea1d94fd4 | a0d519ec-8a3d-4486-8364-e8ed40bef5cb | 2026-08-28 | Warnings | a0d519ec-8a3d-4486-8364-e8ed40bef5cb |
Adverse event summaries are temporarily unavailable. Other product information remains available.